Litcius/Paper detail

Bioavailability of Orally Administered Drugs in Critically Ill Patients

Johanna Forsberg, E. L.R. Bedard, Sherif Hanafy Mahmoud

2022Journal of Pharmacy Practice26 citationsDOIOpen Access PDF

Abstract

Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in unadjusted doses thereby putting the patients at a risk for therapy failure. The objective for this study was to summarize the available evidence regarding oral drug absorption in the ICU. A literature search of the databases MEDLINE, EMBASE, and PubMed was conducted on (February 24, 2020). Articles discussing the rate and/or extent of orally administered drugs in critically ill patients were included. A total of 58 studies were found: 17 interventional studies, 33 observational studies (30 prospective, 3 retrospective) and 8 case reports. A total of 43 articles reported altered drug absorption in critically ill patients suggesting the need for alternative measures to facilitate treatment success. The absorption of orally administered drugs may be altered in critically ill patients. Measures for altered drug absorption in critically ill patients were suggested such as holding tube feeding before and after medication administration, increasing doses of orally administrated drugs and using alternate routes of administration.

Topics & Concepts

MedicineCritically illIntensive care medicineIntensive care unitDrugObservational studyBioavailabilityPharmacokineticsCritical illnessPharmacologyInternal medicinePharmaceutical studies and practicesPharmaceutical Practices and Patient OutcomesPharmacological Effects and Toxicity Studies
Bioavailability of Orally Administered Drugs in Critically Ill Patients | Litcius